STAND. COM. REP. NO. 1779
RE: H.B. No. 1272
Honorable Ronald D. Kouchi
President of the Senate
Thirtieth State Legislature
Regular Session of 2019
State of Hawaii
Your Committee on Commerce, Consumer Protection, and Health, to which was referred H.B. No. 1272, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"
begs leave to report as follows:
The purpose and intent of this measure is to:
(1) Authorize pharmacies to accept the return of any prescription drug for disposal via collection receptacles or mail-back programs;
(2) Prohibit pharmacies from re-dispensing returned prescription drugs or accepting returned prescription drugs in exchange for cash or credit; and
(3) Require the pharmacist-in-charge to ensure that only authorized reverse distributors acquire prescription drugs collected via collection receptacles or mail-back programs.
Your Committee received testimony in support of this measure from the Department of Public Safety; Alcohol and Drug Abuse Division of the Department of Health; Board of Pharmacy; University of Hawai‘i at Hilo, Daniel K. Inouye College of Pharmacy; Hawaii Medical Service Association; Walgreen Co.; Work Injury Medical Association of Hawaii; Hawaii Substance Abuse Coalition; CVS Health; and four individuals.
Your Committee finds that unused medications in households and at various patient care facilities expose residents to potential harm due to mistaken ingestion and increase the potential for theft and assault. Annually, more than seventy-one thousand children under the age of nineteen are admitted to emergency rooms for unintentional overdoses of prescription and over-the-counter drugs. Your Committee further finds that keeping unused opioids or other common drugs of misuse in homes is no longer safe or responsible. Disposal of unwanted, expired, or unnecessary prescription drugs reduces the risk of overdose, prevents unused or unwanted drugs or controlled substances from being diverted to an unintentional user, and avoids contaminating landfills and oceans. This measure helps address the nationwide opioid epidemic and promotes patient safety.
Your Committee has amended this measure by:
(1) Inserting an effective date of July 1, 2019; and
(2) Making a technical, nonsubstantive amendment for the purposes of clarity and consistency.
As affirmed by the record of votes of the members of your Committee on Commerce, Consumer Protection, and Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1272, H.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1272, H.D. 1, S.D. 1, and be placed on the calendar for Third Reading.
Respectfully submitted on behalf of the members of the Committee on Commerce, Consumer Protection, and Health,
ROSALYN H. BAKER, Chair